Pfizer Inc. v. Sanofi Pasteur Inc. (Fed. Cir. 2024) | McDonnell Boehnen Hulbert & Berghoff LLP

Last week, the Federal Circuit handed down its opinion in Pfizer Inc. v. Sanofi Pasteur Inc., affirming the Patent Trial and Appeal Board's (PTAB) determination that all claims of U.S....

Related Keywords

New Zealand ,United States , ,Office Guidance ,Genentech Inc ,Pfizer ,Apotex Inc ,Pfizer Inc ,Challengers Merck Sharp Dohme Corp ,Sanofi Pasteur Inc ,Arthrex Inc ,Ei Dupont De Nemours Co ,Hospira Inc ,Supreme Court ,Sk Chemicals Co Ltd ,Mcdonnell Boehnen Hulbert Berghoff ,Broad Inst Inc ,Mcdonnell Boehnen Hulbert ,Federal Circuit ,Pasteur Inc ,Patent Trial ,Appeal Board ,Merck Sharp ,Sanofi Pasteur ,Application Publication ,Director Review ,Pont De Nemours ,Administrative Procedures Act ,New Zealand White Rabbits ,Circuit Judges Lourie ,Circuit Judge ,